Cardiovascular Nutrition Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, USA.
USDA, ARS, Beltsville Human Nutrition Research Center, Diet Genomics and Immunology Laboratory, Beltsville, Maryland, USA.
J Nutr Biochem. 2021 Apr;90:108570. doi: 10.1016/j.jnutbio.2020.108570. Epub 2021 Jan 8.
Optimizing diet quality in conjunction with statin therapy is currently the most common approach for coronary artery disease (CAD) risk management. Although effects on the cardiovascular system have been extensively investigated, little is known about the effect of these interventions in the colon and subsequent associations with CAD progression. To address this gap, Ossabaw pigs were randomly allocated to receive, for a six-month period, isocaloric amounts of either a heart healthy-type diet (HHD; high in unrefined carbohydrate, unsaturated fat, fiber, supplemented with fish oil, and low in cholesterol) or a Western-type diet (WD; high in refined carbohydrate, saturated fat and cholesterol, and low in fiber), without or with atorvastatin therapy. At the end of the intervention period, colon samples were harvested, mucosa fraction isolated, and RNA sequenced. Gene differential expression and enrichment analyses indicated that dietary patterns and atorvastatin therapy differentially altered gene expression, with diet-statin interactions. Atorvastatin had a more profound effect on differential gene expression than diet. In pigs not receiving atorvastatin, the WD upregulated "LXR/RXR Activation" pathway compared to pigs fed the HHD. Enrichment analysis indicated that atorvastatin therapy lowered inflammatory status in the HHD-fed pigs, whereas it induced a colitis-like gene expression phenotype in the WD-fed pigs. No significant association was identified between gene expression phenotypes and severity of atherosclerotic lesions in the left anterior descending-left circumflex bifurcation artery. These data suggested diet quality modulated the response to atorvastatin therapy in colonic mucosa, and these effects were unrelated to atherosclerotic lesion development.
优化饮食质量与他汀类药物治疗相结合,是目前冠心病(CAD)风险管理最常见的方法。尽管人们对心血管系统的影响进行了广泛的研究,但对于这些干预措施在结肠中的作用及其与 CAD 进展的后续关联却知之甚少。为了解决这一差距,奥萨鲍(Ossabaw)猪被随机分配,在六个月的时间内,接受等热量的心脏健康型饮食(HHD;富含未精制碳水化合物、不饱和脂肪、纤维,补充鱼油,胆固醇含量低)或西方型饮食(WD;富含精制碳水化合物、饱和脂肪和胆固醇,纤维含量低),或不接受阿托伐他汀治疗。在干预期末,采集结肠样本,分离黏膜部分,并进行 RNA 测序。基因差异表达和富集分析表明,饮食模式和阿托伐他汀治疗以不同的方式改变了基因表达,存在饮食-他汀相互作用。与饮食相比,阿托伐他汀对差异基因表达的影响更为显著。在未接受阿托伐他汀治疗的猪中,与 HHD 喂养的猪相比,WD 上调了“LXR/RXR 激活”通路。富集分析表明,阿托伐他汀治疗降低了 HHD 喂养猪的炎症状态,而在 WD 喂养猪中诱导了类似结肠炎的基因表达表型。基因表达表型与左前降支-左回旋支分叉动脉粥样硬化病变的严重程度之间未发现显著相关性。这些数据表明,饮食质量调节了结肠黏膜对阿托伐他汀治疗的反应,这些影响与动脉粥样硬化病变的发展无关。